Related Experiment Video
Updated: Aug 22, 2025

09:05
MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
7.6K
Honokiol and Alpha-Mangostin Inhibit Mayaro Virus Replication through Different Mechanisms
Patricia Valdés-Torres1,2, Dalkiria Campos1, Madhvi Bhakta1
1Grupo de Biología Celular y Molecular de Arbovirus, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panama City 0816-02593, Panama.
Molecules (Basel, Switzerland)
|November 11, 2022
Summary
Honokiol and α-Mangostin show broad-spectrum antiviral activity against arboviruses like Mayaro virus. These natural compounds reduce viral replication and enhance the immune response, offering potential for new treatments.
Area of Science:
- Virology
- Natural Product Chemistry
- Immunology
Background:
- Mayaro virus (MAYV) is an emerging arbovirus spreading in the Americas.
- There is a need for effective antiviral treatments against MAYV and other arboviruses.
Purpose of the Study:
- To evaluate the antiviral potential of six natural compounds against MAYV and other arboviruses.
- To identify compounds with significant antiviral activity and low cytotoxicity.
Main Methods:
- Assessed cytotoxicity of Sanguinarine, (R)-Shikonin, Fisetin, Honokiol, Tanshinone IIA, and α-Mangostin.
- Evaluated the efficacy of promising compounds against MAYV and other arboviruses in cell lines.
- Analyzed viral RNA replication, viral titers, protein expression, and host interferon response.
Main Results:
- Honokiol and α-Mangostin demonstrated significant antiviral activity against MAYV and other arboviruses (Una, Chikungunya, Zika) with low cytotoxicity.
- These compounds reduced viral RNA replication, viral progeny yields, and key viral protein expression.
- Treatment upregulated type I interferon and interferon-stimulated genes, suggesting an enhanced antiviral cellular state.
Conclusions:
- Honokiol and α-Mangostin exhibit promising broad-spectrum antiviral properties against arboviruses.
- These natural compounds may represent novel therapeutic agents for arboviral infections.
- Further research into their mechanisms of action and in vivo efficacy is warranted.
Related Concept Videos
Viruses with RNA Genomes
89
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
89
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
RNA Interference
26.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
Combined Effects of Drugs: Antagonism
9.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.1K

